#1 Clinical Trials Search in Europe

TORASEMIDE

Torasemide (also known as torsemide) is a loop diuretic medication that has been studied extensively in clinical trials for various cardiovascular conditions. This potent diuretic works by inhibiting sodium and chloride reabsorption in the kidneys, increasing urine output and reducing fluid retention in the body. Clinical trials have investigated torasemide in different formulations (immediate-release and extended-release) and compared it with other diuretics like furosemide in conditions such as heart failure, hypertension, and edema. These studies have examined not only the drug’s effectiveness in managing symptoms and improving clinical outcomes but also its pharmacokinetic properties and safety profile across diverse patient populations. Understanding the evidence from these clinical trials helps patients and healthcare providers make informed decisions about using torasemide as part of treatment plans for cardiovascular and renal conditions.

Table of Contents

What is Torasemide?

Torasemide (also spelled as torsemide) is a medication that belongs to a class of drugs called loop diuretics. It is prescribed to remove excess fluid from the body in conditions where fluid retention is a problem. Torasemide is sold under various brand names including Demadex, Tortas, and Wator [1].

As a loop diuretic, torasemide works by preventing your kidneys from absorbing too much salt, which allows the salt to instead be passed in your urine. When salt is filtered from your blood by the kidneys, water is also drawn out, which helps reduce fluid buildup in your body [2].

How Torasemide Works

Torasemide acts on a specific part of the kidney called the ascending loop of Henle. It inhibits what’s known as the Na+/K+/2Cl- transport system and blocks chloride channels. This prevents sodium and chlorine ions from being reabsorbed into your bloodstream, which significantly increases urine volume [3].

By increasing urine production, torasemide helps reduce fluid retention (edema) in the body. This can relieve symptoms like swelling in the legs and ankles, shortness of breath, and can reduce strain on the heart in patients with heart failure [4].

Unlike some other diuretics, torasemide has a longer elimination half-life, which means it stays active in your body for longer periods, potentially allowing for once-daily dosing instead of multiple doses throughout the day [5].

Medical Conditions Treated with Torasemide

Torasemide is prescribed for several medical conditions that involve fluid retention:

Heart Failure

In heart failure, the heart cannot pump blood effectively, leading to fluid buildup in the body. Torasemide helps reduce this fluid accumulation, decreasing the workload on the heart and improving symptoms like shortness of breath and swelling [6]. Studies have shown that torasemide may have additional benefits for heart failure patients beyond its diuretic effects, including potential effects on myocardial remodeling and fibrosis (scarring) [7].

Hypertension (High Blood Pressure)

Torasemide can be used alone or in combination with other medications to treat high blood pressure. By reducing fluid volume in the blood vessels, it helps lower blood pressure [8]. Research suggests that torasemide may be effective in patients with various genetic predispositions to hypertension, including those related to lanosterol and uromodulin genes [1].

Edema (Fluid Retention)

Torasemide is effective in treating edema associated with various conditions:

  • Liver disease (hepatic edema)
  • Kidney disease (renal edema)
  • Fluid in the lungs (pulmonary congestion)
  • Right heart failure with tricuspid regurgitation [4]

Postpartum Hypertension

Research is investigating the use of torasemide for the prevention of persistent hypertension after childbirth in women who had preeclampsia during pregnancy [9].

Different Formulations of Torasemide

Torasemide is available in different formulations, each with its own characteristics:

Immediate Release (IR) Torasemide

This is the standard formulation that releases the medication quickly after taking it. It provides a rapid diuretic effect but may have a shorter duration of action [6]. The immediate release formulation can sometimes cause large and abrupt urination that might lead to incontinence in some patients [10].

Extended Release (ER) or Prolonged Release (PR) Torasemide

This formulation is designed to release the medication more slowly over time, providing a more gradual and prolonged effect. Studies suggest that extended-release torasemide may offer several advantages:

  • More gradual urination, which may be more comfortable and reduce the risk of incontinence [10]
  • Prolonged duration of action, which may improve sodium excretion even when patients consume a high-salt diet [10]
  • Potentially improved effects on reducing symptoms in patients with heart failure and overactive bladder [11]

Recent research is investigating whether extended-release torasemide may enhance sodium excretion after meals (particularly after lunch) compared to immediate-release torasemide, which could provide better fluid control throughout the day [12].

Fixed-Dose Combinations

Research is also exploring the use of torasemide in fixed-dose combinations with other medications, such as spironolactone (a potassium-sparing diuretic) [13]. These combinations may provide complementary effects in managing conditions like heart failure and hypertension.

Torasemide vs. Furosemide

Furosemide (brand name Lasix) is another common loop diuretic that has been used for many years. Several studies have compared torasemide to furosemide:

Similarities

  • Both are loop diuretics that work through similar mechanisms
  • Both effectively reduce fluid retention and edema
  • Both can be used to treat heart failure, hypertension, and edema [14]

Differences and Potential Advantages of Torasemide

  • Longer half-life: Torasemide has a longer elimination time, which may allow for once-daily dosing compared to multiple daily doses of furosemide [5]
  • Better bioavailability: Torasemide is more consistently absorbed when taken orally (around 80-90% compared to furosemide’s more variable 10-100%) [15]
  • Less electrolyte disturbance: Some studies suggest torasemide may cause fewer electrolyte imbalances than furosemide [5]
  • Additional effects: Research indicates torasemide may have additional benefits beyond its diuretic effects, including potential anti-fibrotic effects in the heart, which could be beneficial for heart failure patients [7]

The ongoing TRANSFORM-HF clinical trial is directly comparing torasemide versus furosemide for management of heart failure to determine if one medication offers superior clinical outcomes over the other [16].

Conversion Between Medications

When switching between these medications, the general dosing equivalence is:

  • 1 mg torasemide ≈ 2-4 mg furosemide [16]

For example, if you were taking furosemide 40 mg, you might be switched to torasemide 10-20 mg, though the exact dosing should be determined by your healthcare provider.

Dosage Information

Torasemide dosing depends on the condition being treated and the individual patient. Always follow your healthcare provider’s instructions. General dosing guidelines include:

Heart Failure

  • Starting dose: Usually 10-20 mg once daily
  • Dose may be increased approximately twofold if adequate effect is not achieved [5]

Hypertension

  • Starting dose: 5-10 mg once daily
  • Can be increased up to 20 mg daily if needed, in some cases up to 40 mg [5]

Extended Release Formulations

Dosing for extended-release formulations may differ slightly. For example:

  • 24 mg of extended-release torasemide is often equivalent to 20 mg of immediate-release torasemide [12]

Special Dosing Considerations

Patients with kidney impairment may need adjusted doses based on their level of kidney function. Your healthcare provider will determine the appropriate dose based on your specific situation [15].

Potential Side Effects

Like all medications, torasemide can cause side effects. Not everyone will experience these, and many side effects are manageable with proper monitoring.

Common Side Effects

  • Increased urination: This is an expected effect of the medication
  • Dizziness or lightheadedness: Especially when standing up quickly, due to lowered blood pressure
  • Headache
  • Fatigue or weakness

Electrolyte Imbalances

Torasemide can affect the levels of important minerals in your body, including:

  • Low potassium (hypokalemia): May cause muscle weakness, cramps, or irregular heartbeat [9]
  • Low sodium (hyponatremia): May cause confusion, headache, or seizures in severe cases
  • Low magnesium or calcium: May affect nerve and muscle function

Your doctor will likely monitor your electrolyte levels with blood tests and may recommend supplements or dietary changes if needed.

Less Common but Serious Side Effects

  • Acute kidney injury: Particularly in patients with pre-existing kidney problems [9]
  • Hearing problems: Rarely, reversible hearing loss or ringing in the ears (tinnitus) may occur, especially with high doses [9]
  • Allergic reactions: Such as rash, itching, or in severe cases, difficulty breathing
  • Gout: Torasemide can increase uric acid levels, potentially triggering gout attacks in susceptible individuals

Effects on Breast Milk

For breastfeeding mothers, research is investigating whether torasemide passes into breast milk and its potential effects [9]. Discuss the risks and benefits with your healthcare provider if you are breastfeeding.

Use in Special Populations

Patients with Kidney Impairment

Torasemide can be used in patients with kidney impairment, but dosing may need to be adjusted. Studies show that torasemide can still be effective in patients with moderate to severe renal insufficiency, though careful monitoring is needed [15].

Patients with Heart Failure and Kidney Impairment

Many patients have both heart failure and kidney problems. Research is investigating optimal diuretic strategies for these patients, including the use of torasemide [15].

Pregnant and Postpartum Women

Studies are examining the use of torasemide for preventing persistent hypertension after childbirth in women who had preeclampsia during pregnancy [9]. Always consult with your healthcare provider about medication use during pregnancy or while breastfeeding.

Patients with Overactive Bladder and Heart Failure

Some patients with heart failure also experience symptoms of overactive bladder (frequent urination, urgency, or urgency incontinence). Extended-release torasemide may help manage both conditions by providing a more gradual diuretic effect [11].

Ongoing Research and Future Directions

Several clinical trials are currently investigating various aspects of torasemide treatment:

TRANSFORM-HF Trial

This large study is directly comparing torasemide versus furosemide for management of heart failure to determine if one medication offers superior clinical outcomes in terms of mortality, hospitalizations, and quality of life [16].

Extended Release Formulations

Multiple studies are examining whether extended-release torasemide offers advantages over immediate-release formulations, particularly for:

  • Maintaining natriuretic effects throughout the day, especially after meals [12]
  • Reducing symptoms of overactive bladder in heart failure patients [11]
  • Improving patient comfort and compliance [10]

Personalized Medicine Approaches

Research is investigating whether genetic factors may predict response to torasemide. For example, studies are looking at how variations in genes like uromodulin (UMOD) and lanosterol synthase (LSS) might affect response to torasemide in hypertension treatment [1].

Fixed-Dose Combinations

Development of fixed-dose combinations of torasemide with other medications, such as spironolactone, may provide more convenient and potentially more effective treatment options for heart failure and hypertension [13].

Weight-Based Dosing Strategies

Some researchers are studying whether individualizing torasemide dosing based on a patient’s weight and symptoms might improve outcomes compared to standard fixed-dose regimens [17].

These ongoing research efforts aim to optimize the use of torasemide for various conditions and potentially expand its therapeutic applications.

Aspect Details
Drug Name Torasemide (also called Torsemide)
Drug Class Loop diuretic (pyridine-sulfonylurea)
Mechanism of Action Inhibits Na+/K+/2Cl- transport system and blocks Cl- channels in the ascending loop of Henle in the kidneys, preventing reabsorption of sodium, chloride and water
Primary Conditions Studied Heart failure, hypertension, renal edema, tricuspid regurgitation
Formulations Immediate Release (IR), Extended/Prolonged Release (ER/PR)
Dosage Ranges in Trials 5-48 mg daily (typically 10-20 mg for standard therapy)
Comparison Medications Furosemide (most common), placebo, hydrochlorothiazide
Key Advantages over Furosemide Longer half-life, more predictable absorption, potentially fewer electrolyte disturbances, possible beneficial effects on myocardial fibrosis
Dose Equivalency 1 mg torasemide ≈ 2-4 mg furosemide
Notable Trial Designs Randomized crossover studies, bioequivalence studies, comparisons of IR vs. ER formulations, combination studies with other medications
Common Outcome Measures Urinary sodium excretion, body weight changes, NT-proBNP levels, blood pressure reduction, hospitalization rates, quality of life
Special Populations Patients with renal insufficiency, heart failure with preserved/reduced ejection fraction, postpartum hypertension, patients with genetic predispositions
Pharmacokinetic Parameters Measured through Cmax (peak concentration), AUC (total exposure), t1/2 (half-life), and other parameters in multiple trials
Emerging Research Areas Fixed-dose combinations with spironolactone, weight-based dosing regimens, effects on overactive bladder symptoms, genetic influences on response

FAQ

  • What is torasemide and how does it work? Torasemide (also called torsemide) is a loop diuretic medication that works in the kidneys to increase urine production and reduce fluid retention in the body. It acts on the ascending portion of the Henle loop where it inhibits the Na+/K+/2Cl- transport system and blocks chloride channels. This prevents sodium, chloride, and water from being reabsorbed in the kidney tubules, which significantly increases urine volume. Torasemide is used to treat conditions associated with fluid overload such as heart failure, kidney or liver disease, and hypertension (high blood pressure).
  • How does torasemide compare to furosemide in clinical trials? Clinical trials comparing torasemide to furosemide (another common loop diuretic) have shown several differences. The TRANSFORM-HF trial compared the effects of these medications on clinical outcomes in heart failure patients. Some studies found that torasemide may offer advantages including a longer elimination half-life, similar diuretic effects, fewer electrolyte disturbances, and potential additional beneficial (pleiotropic) effects on the heart. In certain trials, torasemide showed favorable effects on myocardial fibrosis (heart tissue scarring) compared to furosemide. Some studies also suggest torasemide may be associated with better quality of life and potentially fewer hospitalizations, though more research is needed to confirm these findings.
  • What is the difference between immediate-release and extended-release torasemide? Immediate-release (IR) torasemide and extended-release (ER) torasemide differ in how quickly they release the medication in your body. IR torasemide releases the drug quickly, leading to a faster but shorter duration of action with potentially higher peak effects. This can cause large and abrupt urination that might lead to incontinence in some patients. ER torasemide, on the other hand, releases the medication gradually over an extended period, providing a more consistent drug level in the bloodstream. This results in a more gradual diuretic effect which may improve patient comfort and compliance. Several clinical trials have specifically compared these formulations to determine differences in sodium excretion patterns, effectiveness after meals, and overall patient outcomes.
  • What side effects of torasemide were observed in clinical trials? Side effects observed in torasemide clinical trials include fluid and electrolyte imbalances (particularly potassium, sodium, and magnesium), acute kidney injury, and possible effects on hearing (reversible hearing loss or tinnitus). Some patients may experience dehydration if excessive fluid is removed. In bioequivalence studies, researchers carefully monitored for adverse events to ensure the safety of different formulations. While generally well-tolerated, torasemide, like other loop diuretics, requires monitoring of kidney function and electrolyte levels. Specific populations, such as those with severe renal impairment or heart failure, may be more susceptible to certain side effects and require careful dose adjustment.
  • How is torasemide being studied in combination with other medications? Torasemide is being studied in combination with several other medications to enhance treatment effectiveness. Recent trials have investigated fixed-dose combinations (FDC) of extended-release torasemide with spironolactone (a potassium-sparing diuretic) to provide complementary diuretic effects while helping maintain potassium balance. Other studies have examined interactions between torasemide and drugs like empagliflozin (an SGLT2 inhibitor for diabetes), tolvaptan (a vasopressin antagonist), and various antihypertensive medications. In heart failure research, combination approaches are being tested to determine if torasemide paired with other medications can improve outcomes such as reducing hospitalizations, improving symptoms, or affecting biomarkers like NT-proBNP (a marker of heart failure severity).

Ongoing Clinical Trials on TORASEMIDE

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

Glossary

  • Loop Diuretic: A class of medications that act on the ascending loop of Henle in the kidney to inhibit sodium and chloride reabsorption, increasing urine output and reducing fluid retention in the body. Examples include torasemide, furosemide, and bumetanide.
  • Torasemide: A loop diuretic medication (also called torsemide) used to treat edema associated with heart failure, kidney or liver disease, and hypertension. It works by blocking sodium and chloride reabsorption in the kidneys, increasing urine production.
  • Immediate Release (IR) Torsemide: A formulation of torsemide that releases the medication quickly after administration, leading to faster but shorter-lasting effects. This conventional formulation may cause large and abrupt urination.
  • Extended Release (ER) Torsemide: A formulation of torsemide designed to release the medication gradually over an extended period, providing more consistent drug levels and potentially more gradual diuresis to improve patient comfort and compliance.
  • Heart Failure: A condition where the heart cannot pump blood effectively to meet the body's needs. It often leads to fluid retention and symptoms like shortness of breath, fatigue, and swelling of the legs.
  • Hypertension: High blood pressure, a condition where the force of blood against artery walls is consistently too high. It's a major risk factor for heart disease and stroke.
  • Edema: Swelling caused by excess fluid trapped in the body's tissues, often in the feet, ankles, and legs. It can result from heart failure, kidney disease, liver disease, or medication side effects.
  • Natriuresis: The process of sodium excretion in the urine. Diuretics like torasemide promote natriuresis to reduce fluid retention in the body.
  • Bioequivalence: A comparison of the bioavailability (the amount of drug that enters circulation) between two formulations of the same drug. Bioequivalent medications have the same rate and extent of absorption.
  • Pharmacokinetics: The study of how drugs move through the body, including absorption, distribution, metabolism, and excretion. Parameters include Cmax (maximum concentration), AUC (area under the curve), and half-life.
  • NYHA Classification: New York Heart Association Classification, a system that categorizes heart failure patients into four classes (I-IV) based on the severity of their symptoms and limitations during physical activity.
  • NT-proBNP: N-terminal pro B-type natriuretic peptide, a hormone released when the heart is under stress. It's used as a biomarker to diagnose and monitor heart failure.
  • Myocardial Fibrosis: The formation of scar tissue in the heart muscle, often due to injury or stress. Some studies suggest torasemide may have beneficial effects on reducing myocardial fibrosis compared to other diuretics.
  • Spironolactone: A potassium-sparing diuretic that works by blocking the effects of aldosterone. It's often used in combination with loop diuretics like torasemide to prevent potassium loss.
  • Fixed Dose Combination (FDC): A pill that contains two or more active pharmaceutical ingredients combined in a fixed ratio. Some clinical trials have studied FDCs of torasemide with other medications like spironolactone.
  • Renal Insufficiency: Reduced kidney function that can affect how medications like torasemide are processed and eliminated from the body, potentially requiring dose adjustments.
  • Crossover Study Design: A research method where participants receive different treatments in sequence, allowing each person to serve as their own control. Many torasemide trials use this design to compare different formulations or medications.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body, including the mechanism of action and the relationship between drug concentration and effect.
  • Overactive Bladder (OAB): A condition characterized by urinary urgency, frequency, and sometimes incontinence. Some studies have investigated how different formulations of torasemide might affect OAB symptoms in heart failure patients.
  • Electrolyte Disturbances: Imbalances in essential minerals like potassium, sodium, and magnesium in the body, which can occur as side effects of diuretic therapy and require monitoring.

References

  1. https://clinicaltrials.gov/study/NCT06413082
  2. https://clinicaltrials.gov/study/NCT01942109
  3. https://clinicaltrials.gov/study/NCT00334386
  4. https://clinicaltrials.gov/study/NCT02644616
  5. https://clinicaltrials.gov/study/NCT02087332
  6. https://clinicaltrials.gov/study/NCT01549158
  7. https://clinicaltrials.gov/study/NCT00409942
  8. https://clinicaltrials.gov/study/NCT03354897
  9. https://clinicaltrials.gov/study/NCT02813551
  10. https://clinicaltrials.gov/study/NCT03214874
  11. https://clinicaltrials.gov/study/NCT06206512
  12. https://clinicaltrials.gov/study/NCT06176794
  13. https://clinicaltrials.gov/study/NCT07015671
  14. https://clinicaltrials.gov/study/NCT05093621
  15. https://clinicaltrials.gov/study/NCT01558674
  16. https://clinicaltrials.gov/study/NCT03296813
  17. https://clinicaltrials.gov/study/NCT03187509